Table 1.
Socio-economic analysis of toxoplasmosis research of the ten most active countries. Sources for GDP and GDP per capita in 2012: [37–40]
| Country | Number of publications | GDP in 1000 Bio US-$ | Publications/GDP in 1000 Bio US-$ | GDP per capita in 1000 US-$ | Publications/GDP per capita | Type of country |
|---|---|---|---|---|---|---|
| Switzerland | 372 | 0.6312 | 589.35 (1) | 78.93 | 4.71 (10) | HI |
| France | 1425 | 2.6139 | 545.16 (2) | 39.76 | 35.84 (4) | HI |
| UK | 1204 | 2.4767 | 486.13 (3) | 38.65 | 31.15 (5) | HI |
| Brazil | 973 | 2.2531 | 431.84 (4) | 11.32 | 85.95 (2) | UMI |
| US | 5054 | 16.2446 | 311.11 (5) | 51.76 | 97.65 (1) | HI |
| Germany | 1051 | 3.4295 | 306.45 (6) | 42.60 | 24.67 (6) | HI |
| Australia | 397 | 1.5417 | 257.50 (7) | 67.44 | 5.88 (9) | HI |
| Italy | 328 | 2.0141 | 162.85 (8) | 33.81 | 9.70 (8) | HI |
| Japan | 553 | 5.9603 | 92.78 (9) | 46.55 | 11.88 (7) | HI |
| China | 319 | 8.221 | 38.80 (10) | 6.09 | 52.35 (3) | UMI |
HI high-income, UMI upper-middle-income